Medicinal Herbs in the Relief of Neurological, Cardiovascular, and Respiratory Symptoms after COVID-19 Infection A Literature Review
- PMID: 35741026
- PMCID: PMC9220793
- DOI: 10.3390/cells11121897
Medicinal Herbs in the Relief of Neurological, Cardiovascular, and Respiratory Symptoms after COVID-19 Infection A Literature Review
Abstract
COVID-19 infection causes complications, even in people who have had a mild course of the disease. The most dangerous seem to be neurological ailments: anxiety, depression, mixed anxiety-depressive (MAD) syndromes, and irreversible dementia. These conditions can negatively affect the respiratory system, circulatory system, and heart functioning. We believe that phytotherapy can be helpful in all of these conditions. Clinical trials confirm this possibility. The work presents plant materials (Valeriana officinalis, Melissa officinalis, Passiflora incarnata, Piper methysticum, Humulus lupulus, Ballota nigra, Hypericum perforatum, Rhodiola rosea, Lavandula officinalis, Paullinia cupana, Ginkgo biloba, Murraya koenigii, Crataegus monogyna and oxyacantha, Hedera helix, Polygala senega, Pelargonium sidoides, Lichen islandicus, Plantago lanceolata) and their dominant compounds (valeranon, valtrate, apigenin, citronellal, isovitexin, isoorientin, methysticin, humulone, farnesene, acteoside, hypericin, hyperforin, biapigenin, rosavidin, salidroside, linalool acetate, linalool, caffeine, ginkgolide, bilobalide, mihanimbine, epicatechin, hederacoside C,α-hederine, presegenin, umckalin, 6,7,8-trixydroxybenzopyranone disulfate, fumaroprotocetric acid, protolichesteric acid, aucubin, acteoside) responsible for their activity. It also shows the possibility of reducing post-COVID-19 neurological, respiratory, and cardiovascular complications, which can affect the functioning of the nervous system.
Keywords: COVID-19; complications; medicinal herbs; phytotherapy; viral infections.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence.CNS Drugs. 2013 Apr;27(4):301-19. doi: 10.1007/s40263-013-0059-9. CNS Drugs. 2013. PMID: 23653088 Review.
-
Phytotherapy of mood disorders in the light of microbiota-gut-brain axis.Phytomedicine. 2023 Mar;111:154642. doi: 10.1016/j.phymed.2023.154642. Epub 2023 Jan 4. Phytomedicine. 2023. PMID: 36641978 Review.
-
Do recent research studies validate the medicinal plants used in British Columbia, Canada for pet diseases and wild animals taken into temporary care?J Ethnopharmacol. 2019 May 23;236:366-392. doi: 10.1016/j.jep.2019.02.030. Epub 2019 Feb 15. J Ethnopharmacol. 2019. PMID: 30772483 Review.
-
Anti-anxiety Properties of Selected Medicinal Plants.Curr Pharm Biotechnol. 2022;23(8):1041-1060. doi: 10.2174/1389201022666210122125131. Curr Pharm Biotechnol. 2022. PMID: 33480339 Review.
-
Adverse effects of herbal medicines: an overview of systematic reviews.Clin Med (Lond). 2013 Feb;13(1):7-12. doi: 10.7861/clinmedicine.13-1-7. Clin Med (Lond). 2013. PMID: 23472485 Free PMC article. Review.
Cited by
-
Structural and Functional Characterization of Medicinal Plants as Selective Antibodies towards Therapy of COVID-19 Symptoms.Antibodies (Basel). 2024 May 7;13(2):38. doi: 10.3390/antib13020038. Antibodies (Basel). 2024. PMID: 38804306 Free PMC article.
-
Neuroprotective effects of acteoside in a glaucoma mouse model by targeting Serta domain-containing protein 4.Int J Ophthalmol. 2024 Apr 18;17(4):625-637. doi: 10.18240/ijo.2024.04.04. eCollection 2024. Int J Ophthalmol. 2024. PMID: 38638260 Free PMC article.
-
Precision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in long-COVID.NPJ Sci Food. 2024 Mar 30;8(1):19. doi: 10.1038/s41538-024-00261-2. NPJ Sci Food. 2024. PMID: 38555403 Free PMC article. Review.
-
Hyperforin modulates MAPK/CCL11 signaling to reduce the inflammatory response of nasal mucosal epithelial cells caused by allergic rhinitis by targeting BCL6.Exp Ther Med. 2023 Oct 27;26(6):579. doi: 10.3892/etm.2023.12278. eCollection 2023 Dec. Exp Ther Med. 2023. PMID: 38023351 Free PMC article.
-
Remnants from the Past: From an 18th Century Manuscript to 21st Century Ethnobotany in Valle Imagna (Bergamo, Italy).Plants (Basel). 2023 Jul 24;12(14):2748. doi: 10.3390/plants12142748. Plants (Basel). 2023. PMID: 37514363 Free PMC article.
References
-
- Am S., Em A. Medicinal Plants with Antiviral Properties to Tackle COVID-19 Pandemic: A Short-Review. SunText Rev. Biotechnol. 2021;2:122. doi: 10.51737/2766-5097.2021.022. - DOI
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical